IBDEI0HM ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7933,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,7933,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,7933,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,7934,0)
 ;;=L29.9^^39^391^291
 ;;^UTILITY(U,$J,358.3,7934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7934,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,7934,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,7934,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,7935,0)
 ;;=L30.0^^39^391^270
 ;;^UTILITY(U,$J,358.3,7935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7935,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,7935,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,7935,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,7936,0)
 ;;=L30.1^^39^391^143
 ;;^UTILITY(U,$J,358.3,7936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7936,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,7936,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,7936,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,7937,0)
 ;;=L30.2^^39^391^135
 ;;^UTILITY(U,$J,358.3,7937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7937,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,7937,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,7937,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,7938,0)
 ;;=L30.4^^39^391^147
 ;;^UTILITY(U,$J,358.3,7938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7938,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,7938,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,7938,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,7939,0)
 ;;=L30.8^^39^391^138
 ;;^UTILITY(U,$J,358.3,7939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7939,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,7939,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,7939,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,7940,0)
 ;;=L30.9^^39^391^139
 ;;^UTILITY(U,$J,358.3,7940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7940,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,7940,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,7940,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,7941,0)
 ;;=L40.0^^39^391^293
 ;;^UTILITY(U,$J,358.3,7941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7941,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,7941,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,7941,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,7942,0)
 ;;=L40.1^^39^391^296
 ;;^UTILITY(U,$J,358.3,7942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7942,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,7942,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,7942,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,7943,0)
 ;;=L40.2^^39^391^12
 ;;^UTILITY(U,$J,358.3,7943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7943,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,7943,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,7943,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,7944,0)
 ;;=L40.3^^39^391^295
 ;;^UTILITY(U,$J,358.3,7944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7944,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,7944,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,7944,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,7945,0)
 ;;=L40.4^^39^391^160
 ;;^UTILITY(U,$J,358.3,7945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7945,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,7945,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,7945,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,7946,0)
 ;;=L40.8^^39^391^292
 ;;^UTILITY(U,$J,358.3,7946,1,0)
 ;;=^358.31IA^4^2
